Related Articles
The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR‑TKIs but is not an indication of acquired resistance to EGFR‑TKIs in NSCLC patients with EGFR mutations
Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
<sup>18</sup>F‑FDG PET/CT SUV<sub>max</sub> and serum CEA levels as predictors for EGFR mutation state in Chinese patients with non‑small cell lung cancer
Effect of hydrothorax EGFR gene mutation and EGFR‑TKI targeted therapy on advanced non‑small cell lung cancer patients